Skip to content
Brand AI

MPM BioImpact

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2026

    K2 Therapeutics secures US$50 million seed round

    Singapore-based biotech company K2 Therapeutics announced on Aug 11 that it secured a US$50 million seed round, initially seeded by MPM BioImpact, to support expansion of its portfolio and advance its assets.

    Source